Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study
Yutaka Sugawara, Momoko Kobayashi, Eri Mannoji, Tomoya Saika, Yuki Kado, Michiko Yamazaki, Tohru Takebe, Hajime Higuchi · 2026
Read Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study by Yutaka Sugawara, Momoko Kobayashi, Eri Mannoji, Tomoya Saika, Yuki Kado, Michiko Yamazaki, Tohru Takebe, Hajime Higuchi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13284108.txt.
Description
Yutaka Sugawara and colleagues tested in 2026 whether cancer patients can report chemotherapy side effects weekly on their own phones. Electronic symptom reporting can improve monitoring, yet using personal devices in routine care, mainly among older adults, was unproven. Twenty-eight outpatients in Japan answered weekly standard symptom questionnaires for twelve weeks, and alerts fired automatically when severity or frequency passed set marks.
Mean age was about sixty-seven, and most patients had stage four disease. Weekly response rates ran from 75 to 93 percent overall and stayed at or above 75 percent among patients aged seventy and over. Pain triggered the most alerts, then numbness and tingling, rash, fatigue, and skin problems. Quality of life scores rose slightly over the study with no marked decline.
Catalog record
| CREATOR | Yutaka Sugawara, Momoko Kobayashi, Eri Mannoji, Tomoya Saika, Yuki Kado, Michiko Yamazaki, Tohru Takebe, Hajime Higuchi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |